David E. Lazar - 16 Oct 2025 SCHEDULE 13D/A Report for NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY)

Filing Manager: David E. Lazar
Reporting Manager: David E. Lazar
Security: NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value
Symbol: NBY
Shares outstanding: 7.51M shares
Disclosed Ownership: 1.5M shares
Ownership: 20%
Form type: SCHEDULE 13D/A
Date filed: 17 Oct 2025, 17:29
Date of event: 16 Oct 2025
Previous filing: 26 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
David E. Lazar	19.99%	1.5M	1.5M	0	/s/ David E. Lazar	David E. Lazar	0001932843